Science Explorer Interactive view Map
Company · Seattle · United States

Kineta (United States)

kinetabio.comROR OpenAlex
Research works
38
▲ 12% vs 2013–17
Citations
402
10.6 per fractional work
Top-10% rate
9.2%
record average 16.5%
Open access
54%
world 28%

Not ranked overall: Kineta (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.13× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 20.96× its world share, 2 worksImmunology and Micro…Computer Science: 0.73× its world share, 1 worksComputer ScienceHealth Professions: 0.36× its world share, 0 worksHealth ProfessionsMedicine: 2.87× its world share, 6 worksMedicineDecision Sciences: 5.91× its world share, 1 worksDecision Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 21.0×. Every wedge is a field page.

Which keywords describe research at Kineta (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Tumor Microenvironment, Cancer Immunotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Innate Immunity, Glycosylation, Monoclonal Antibodies and Therapeutic Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Tumor Microenvironment4▲ 33×2 topics
  2. Cancer Immunotherapy4▲ 82×2 topics
  3. Immune Checkpoint Blockade4▲ 181×1 topic
  4. PD-1 and PD-L14▲ 181×1 topic
  5. Innate Immunity4▲ 28×2 topics
  6. Glycosylation3▲ 38×2 topics
  7. Monoclonal Antibodies3▲ 51×2 topics
  8. Therapeutic Antibodies3▲ 57×2 topics
  9. Antibody Engineering3▲ 72×1 topic
  10. Fc Receptors3▲ 72×1 topic
  11. Immunity3▲ 21×5 topics
  12. Lymphoma3▲ 47×2 topics
  13. Inflammation2▲ 2.8×7 topics
  14. Immunotherapy2▲ 9.7×2 topics
  15. Tumor Regression2▲ 72×2 topics
  16. CAR T Cells2▲ 142×1 topic
  17. Chimeric Antigen Receptor2▲ 142×1 topic
  18. Dendritic Cells2▲ 53×2 topics
  19. Epidemiology2▲ 1.53×12 topics
  20. Pattern Recognition Receptors2▲ 40×2 topics
  21. Antigen Presentation2▲ 53×1 topic
  22. Tumor Antigen2▲ 65×1 topic
  23. Cancer2▲ 3.4×4 topics
  24. Pathogenesis2▲ 8.5×5 topics
  25. Viral Infection2▲ 66×2 topics
  26. Interferon Signaling2▲ 137×1 topic
  27. NK Cell Recognition2▲ 45×1 topic
  28. Natural Killer Cells2▲ 45×1 topic
  29. cGAS-STING Pathway2▲ 137×1 topic
  30. Immune Response2▲ 7.0×5 topics
  31. Ion Channels2▲ 20×4 topics
  32. Cell Signaling1▲ 11×2 topics
  33. Calcium Channels1▲ 47×1 topic
  34. Medicinal Chemistry1▲ 9.4×2 topics
  35. Voltage-Gated Channels1▲ 47×1 topic
  36. Genetic Mutations1▲ 5.9×1 topic
  37. Primary Immunodeficiency1▲ 76×1 topic
  38. Prognostic Factors1▲ 6.8×2 topics
  39. Quinoxaline1▲ 68×1 topic
  40. Rituximab1▲ 18×3 topics

Which research topics does Kineta (United States) publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, CAR-T cell therapy research and Immunotherapy and Immune Responses.

Cancer Immunotherapy and Biomarkers: 2 fractional worksImmune Cell Function and Interaction: 1 fractional worksCAR-T cell therapy resea…1CAR-T cell therapy research: 1 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksMathematics, Computing, and Information Processing: 1 fractional worksScientific Computing and…1Scientific Computing and Data Management: 1 fractional worksCell Image Analysis Techniques: 1 fractional worksAcute Myeloid Leukemia Research: 0 fractional worksViral Infections and Outbreaks Research: 0 fractional works
OncologyImmunologyRadiology, Nuclear Medicine and ImagingComputational Theory and Mathematics4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 2 works
  2. 2 Immune Cell Function and Interaction Immunology 1 works
  3. 3 CAR-T cell therapy research Oncology 1 works
  4. 4 Immunotherapy and Immune Responses Immunology 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  6. 6 Mathematics, Computing, and Information Processing Computational Theory and Mathematics 1 works
  7. 7 Scientific Computing and Data Management Information Systems and Management 1 works
  8. 8 Cell Image Analysis Techniques Biophysics 1 works
  9. 9 Acute Myeloid Leukemia Research Hematology 0 works
  10. 10 Viral Infections and Outbreaks Research Infectious Diseases 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.8%not open46.2%

World: 28% of research is openly available.

with international co-authors12.9%domestic only87.1%

World: 19% is written across borders.

How has Kineta (United States)'s research output changed?

Output in 2018–2022 was 12% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seattle

All research institutions in Seattle

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.